Mihaela Cristea

Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum‐Gamez et al. · Journal of the National Comprehensive Cancer Network · 2021 · 688 citations · Full text

Surgical Oncology, Epithelial Ovarian Cancer, Cancer Management +19

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller et al. · The Lancet Oncology · 2019 · 516 citations

Oncology, Metronomic Therapy, Gynecology +6

NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022

Deborah K. Armstrong, Ronald D. Alvarez, Floor Backes et al. · Journal of the National Comprehensive Cancer Network · 2022 · 369 citations · Full text

Nccn Guidelines® Insights, Tumoral Pathology, Endocrine-related Cancer +13

NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019

Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum‐Gamez et al. · Journal of the National Comprehensive Cancer Network · 2019 · 323 citations · Full text

Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial

Stéphanie Lheureux, Mihaela Cristea, Jeffrey P. Bruce et al. · The Lancet · 2021 · 204 citations · Full text

Medicine, Metronomic Therapy, Clinical Trials +7